Available now: Open-access interviews with experts on the COVID-19 pandemic: epidemiology, virus biology and possible vaccines and treatmentsView All
Dr. Alastair Noyce Institute of Neurology, University College London, UK1 Talk
Alastair Noyce heads up the PREDICT-PD study which seeks to define a group of people at increased risk of Parkinson’s disease for the purpose of early intervention with neuroprotective drugs. He studied medicine at Barts and the London Medical School and after graduating, pursued dual clinical and academic training in... read moregeneral medicine and neurology. He is currently working towards a PhD funded by Parkinson’s UK.